Intravenous Solutions (Colloids) Market
Intravenous Solutions (Colloids) Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Intravenous Solutions (Colloids) Market Size and Growth
The Intravenous Solutions (Colloids) market exhibits significant growth, driven by rising healthcare demands and innovative product developments. In 2023, the market size is estimated at approximately $3 billion, with a projected CAGR of 6% through 2030. Key drivers include increased hospitalizations and advancements in medical technologies enhancing patient care.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ ICU Medical Inc.
◍ B. Braun Melsungen AG
◍ Fresenius Kabi AG
◍ Baxter
◍ Amanta Healthcare
◍ Terumo Medical Corporation
◍ Grifols S.A.
The intravenous solutions (colloids) market is competitive, featuring key players like ICU Medical Inc., B. Braun Melsungen AG, and Fresenius Kabi AG. These companies enhance market growth through innovative product offerings and strategic partnerships. Notable sales revenues include Fresenius Kabi with around $6 billion and Baxter at approximately $11 billion.
Request Sample Report
Market Segmentation
By Application
By Product
◍ Total Parenteral Nutrition ◍ Hospital and Clinics ◍ Ambulatory ◍ Home Care
◍ Peripheral Parenteral Nutrition
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
